rs848

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NM_002188.3(IL13):c.*526A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.68 (AC=108,015) in the gnomAD database across 158,878 control chromosomes, including 38,217 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.797. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.68 ( 36320 hom., cov: 31)
Exomes 𝑓: 0.72 ( 1897 hom. )

Consequence

IL13
NM_002188.3 3_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.18

Publications

137 publications found
Variant links:
Genes affected
IL13 (HGNC:5973): (interleukin 13) This gene encodes an immunoregulatory cytokine produced primarily by activated Th2 cells. This cytokine is involved in several stages of B-cell maturation and differentiation. It up-regulates CD23 and MHC class II expression, and promotes IgE isotype switching of B cells. This cytokine down-regulates macrophage activity, thereby inhibits the production of pro-inflammatory cytokines and chemokines. This cytokine is found to be critical to the pathogenesis of allergen-induced asthma but operates through mechanisms independent of IgE and eosinophils. This gene, IL3, IL5, IL4, and CSF2 form a cytokine gene cluster on chromosome 5q, with this gene particularly close to IL4. [provided by RefSeq, Jul 2008]
TH2LCRR (HGNC:40495): (T helper type 2 locus control region associated RNA)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_002188.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Benign. The variant received -12 points.

BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BA1Stand-alone benign allele frequency (>5%)
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.7972 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_002188.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL13
NM_002188.3
MANE Select
c.*526A>C
3_prime_UTR
Exon 4 of 4NP_002179.2
IL13
NM_001354991.2
c.*526A>C
3_prime_UTR
Exon 5 of 5NP_001341920.1Q4VB53
IL13
NM_001354992.2
c.*526A>C
3_prime_UTR
Exon 6 of 6NP_001341921.1Q4VB53

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL13
ENST00000304506.7
TSL:1 MANE Select
c.*526A>C
3_prime_UTR
Exon 4 of 4ENSP00000304915.3P35225
TH2LCRR
ENST00000435042.1
TSL:5
n.94+3371T>G
intron
N/A
IL13
ENST00000459878.5
TSL:3
n.*194A>C
downstream_gene
N/A

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 5 sources
GnomAD3 genomes
AF: 0.678
AC:102993
Hom:36321
AN:151830
Cov:31
GnomAD4 exome
AF: 0.721
AC:4995
Hom:1897
AN:6932
Cov:0
GnomAD4 genome
AF: 0.678
AC:103020
Hom:36320
AN:151946
Cov:31
TOPMed (Bravo)
AF: 0.669
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.757
AC:153458
Hom:59156
AN:202784
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.724
AC:1695
Hom:621
AN:2342
ChinaMAP Phase 1
AF: 0.684
Denmark Genome
AF: 0.800
AC:240
AN:300
GenomeAsia100K
AF: 0.665
AC:2315
AN:3478
Korea4K (4,157 Koreans)
AF: 0.681
AC:4927
AN:7232
Qatari Genome
AF: 0.818
AC:144
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.691
AC:84741
Hom:29255
AN:122710
Turkish Variome
AF: 0.763
AC:1176
Hom:448
AN:1542
UK10K
AF: 0.813
AC:6145
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.682
AC:6108
Hom:2097
AN:8960
Showing 15 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
SCHEMA
(Schizophrenia)
0.257 593423106 0.125 370529590
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign0.14
BayesDel_noAF
Benign-0.84
CADD
Benign1.1
DANN
Benign0.75
GPN-Star LLR
N/A-2.0
GPN-Star score
N/A2.0
Mutation Taster
N/A100/0polymorphism (auto)
PhyloP100
Benign-1.2
Showing 8 of 8 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.